HomeNewsBusinessUSCIS to begin premium processing of H-1B visas, green cards in phases from June 1, 2020

USCIS to begin premium processing of H-1B visas, green cards in phases from June 1, 2020

USCIS suspended temporarily premium processing for H-1B visas and employment-based green cards due to COVID-19 outbreak.

May 29, 2020 / 23:12 IST
Story continues below Advertisement

United States Citizenship and Immigration Services (USCIS) will resume premium processing of H-1B petitions and employment-based green card petitions in phases from June 1, 2020.

On March 20, USCIS suspended temporarily premium processing for all Form I-129 (H-1B) and I-140 petitions (employment-based green card applications) due to the COVID-19 outbreak.

Story continues below Advertisement

"USCIS continues to process any petition with a previously accepted Form I-907 (request for premium processing), in accordance with the premium processing service criteria," it said in a statement.

On June 1, premium processing will begin for all eligible employment-based green card petitions. From June 8, H-1B petitions that are pending adjudication and those that are cap-exempt, which are jobs exempt from the annual cap on foreign workers holding H-1B visa.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show